within Pharmacolibrary.Drugs.ATC.V;

model V03AB20
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.0003333333333333333,
    adminDuration  = 600,
    adminMass      = 0.002,
    adminCount     = 1,
    Vd             = 0.0007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Copper sulfate is an inorganic compound used primarily as a source of copper for treatment of copper deficiency and as an antidote in phosphorus poisoning. It has also been used as an emetic and fungicide, but is not widely used as a medicinal agent today due to safety concerns and the availability of safer alternatives.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic model for healthy adults, as no direct human pharmacokinetic studies or referenced publications on copper sulfate PK are available.</p><h4>References</h4><ol><li><p>Jameson, S, et al., &amp; Magnusson, S (1985). Copper malabsorption in coeliac disease. <i>The Science of the total environment</i> 42(1-2) 29–36. DOI:<a href=&quot;https://doi.org/10.1016/0048-9697(85)90004-x&quot;>10.1016/0048-9697(85)90004-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4012287/&quot;>https://pubmed.ncbi.nlm.nih.gov/4012287</a></p></li><li><p>Bhuia, MS, et al., &amp; Islam, MT (2023). Modulatory effects of phytol on the antiemetic property of domperidone, possibly through the D. <i>3 Biotech</i> 13(4) 116–None. DOI:<a href=&quot;https://doi.org/10.1007/s13205-023-03520-3&quot;>10.1007/s13205-023-03520-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36919029/&quot;>https://pubmed.ncbi.nlm.nih.gov/36919029</a></p></li><li><p>Bareggi, SR, &amp; Cornelli, U (2012). Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. <i>CNS neuroscience &amp; therapeutics</i> 18(1) 41–46. DOI:<a href=&quot;https://doi.org/10.1111/j.1755-5949.2010.00231.x&quot;>10.1111/j.1755-5949.2010.00231.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21199452/&quot;>https://pubmed.ncbi.nlm.nih.gov/21199452</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V03AB20;
